9PT Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Pliant Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.878 EUR -2.88%

Market Cap: €52.5m

P	Pliant Therapeutics Inc F:9PT	US
P	Pultegroup Inc XMUN:PU7	US
	Fortinet Inc NASDAQ:FTNT	US
	Bayan Resources Tbk PT F:BNB	ID
	Threat Protect Australia Ltd ASX:TPS	AU
L	Lam Research Corp XHAM:LAR	US
U	UniCredit SpA OTC:UNCRY	IT
	Commerzbank AG MIL:CBK	DE
C	China Southern Airlines Co Ltd XMUN:ZNHH	CN
B	Berry Global Group Inc F:BP0	US
F	Fairfax Financial Holdings Ltd SWB:FFX	CA
R	Rush Enterprises Inc F:RUNA	US
	China Merchants Bank Co Ltd F:M4BB	CN

Profitability Summary

Pliant Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Low Operating Margin

Negative 3Y Average Operating Margin

-31 450%

Low Net Margin

Negative 3Y Average Net Margin

-27 628%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-19 448%

Negative ROE

-62%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-800%

ROIC is Increasing

-900% > -442%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.